欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是

中国临床药理学与治疗学 ›› 2022, Vol. 27 ›› Issue (5): 575-587.doi: 10.12092/j.issn.1009-2501.2022.05.011

• 综述与讲座 • 上一篇    下一篇

结直肠癌和microRNA:研究进展

周广琛1,刘怡希2,郑云3   

  1. 1昆明理工大学信息工程与自动化学院,昆明 650500,云南;2昆明医科大学第一附属医院,云南省心脑血管疾病临床医学中心,昆明 650032,云南;3昆明理工大学省部共建非人灵长类生物医学国家重点实验室,灵长类转化医学研究院,昆明 650500,云南

  • 收稿日期:2022-01-30 修回日期:2022-04-06 出版日期:2022-05-26 发布日期:2022-06-06
  • 通讯作者: 刘怡希,女,博士,主治医师,研究方向:miRNA临床医学应用研究。 E-mail: doctorliuyixi@163.com 郑云,男,博士,教授,研究方向:miRNA生物信息学研究。 E-mail: zhengyun@fudan.edu.cn
  • 作者简介:周广琛,男,硕士在读。 E-mail: guangchenzhou2019@163.com
  • 基金资助:
    科技部国家重点研发计划课题(2018YFA0108502);国家自然科学基金(31760314);云南心脑血管疾病临床医学中心(ZX2019-03-01)

Colorectal cancer and microRNA: research progress

ZHOU Guangchen1, LIU Yixi2, ZHENG Yun3   

  1. 1Faculty of Information Engineering and Automation, Kunming University of Science and Technology, Kunming 650500, Yunnan, China; 2The First Affiliated Hospital of Kunming Medical University, Yunnan Cardiovascular and Cerebrovascular Disease Clinical Medical Center, Kunming 650032, Yunnan, China; 3Institute of Primate Translational Medicine, State Key Laboratory of Non-Human Primate Biomedicine, Kunming University of Science and Technology, Kunming 650051, Yunnan, China
  • Received:2022-01-30 Revised:2022-04-06 Online:2022-05-26 Published:2022-06-06

摘要: 结直肠癌(colorectal cancer, CRC)在世界范围内发病率和致死率一直都居高不下,其病变与基因突变、表观遗传改变和相关信号通路激活有关。microRNA(miRNA)是一类长度为20~24 nt的非编码RNA,可以调控靶标mRNA的表达并控制各种细胞机制。作为CRC的治疗和预后的新型标志物,miRNA与CRC的发生和发展密切相关。在本综述中,我们就CRC组织中失调的miRNA进行了总结,分析了特异性miRNA与CRC增殖、转移、凋亡、化疗之间的关系,并介绍了miRNA在CRC治疗和预后上的临床应用。

关键词: miRNA, 结直肠癌, 标志物, 调控

Abstract:

Colorectal cancer (CRC) has a high incidence and mortality rate worldwide. Its lesions are associated to gene mutation, epigenetic changes and activation of related signaling pathways. microRNAs (miRNAs) are a class of non-coding RNAs of 20-24 nt in length that can regulate the expression of target mRNAs and control various cellular mechanisms. As a novel marker for the treatment and prognosis of colorectal cancer, miRNAs are closely related to the occurrence and progression of colorectal cancer. In this review, we summarize the miRNAs dysregulated in CRC tissues, analyze the relationship between specific miRNAs and CRC proliferation, metastasis, apoptosis, and chemotherapy, and present the clinical applications of miRNAs in CRC treatment and prognosis.

Key words: miRNA, colorectal cancer, biomarkers, regulation

中图分类号: